LEO Pharma and PellePharm Announce $760 Million Collaboration to Advance Innovative Therapies for…
Danish dermatology specialists LEO Pharma and California rare disease pioneers PellePharm announced a strategic development and commercialization collaboration to address unmet medical…
Read More...
Read More...
